A little CIN may cost a lot: revisiting aneuploidy and cancer

Current Opinion in Genetics and Development

Volumn 19, Issue 1, 2009, Pages 74-81

  Chandhok, Namrata S ^a   Pellman, David ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ANEUPLOIDY; CANCER INHIBITION; CHROMOSOMAL INSTABILITY; GENE MUTATION; HUMAN; PRIORITY JOURNAL; REVIEW; TELOMERE; TUMOR GROWTH;

ANEUPLOIDY; CHROMOSOME ABERRATIONS; FORECASTING; MODELS, GENETIC; NEOPLASMS;

EID: 60949102816     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2008.12.004     Document Type: Review

References (65)

1. Boveri T. Zur Frage der Entstehung maligner Tumoren (1914), Jena, Gustav Fisher Verlag, Germany
2. Weinberg R.A. The Biology of Cancer (2006), Garland Science
3. Duesberg P. Chromosomal chaos and cancer. Sci Am 296 (2007) 52-59
4. Ricke R.M., van Ree J.H., and van Deursen J.M. Whole chromosome instability and cancer: a complex relationship. Trends Genet 24 (2008) 457-466
5. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instability in colorectal cancers. Nature 386 (1997) 623-627
6. Geigl J.B., Obenauf A.C., Schwarzbraun T., and Speicher M.R. Defining 'chromosomal instability'. Trends Genet 24 (2008) 64-69
7. Storchova Z., and Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5 (2004) 45-54
8. Rajagopalan H., and Lengauer C. Aneuploidy and cancer. Nature 432 (2004) 338-341
9. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression?. Nat Rev Cancer 2 (2002) 815-825
10. Cahill D.P., Lengauer C., Yu J., Riggins G.J., Willson J.K., Markowitz S.D., Kinzler K.W., and Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature 392 (1998) 300-303
11. Musacchio A., and Salmon E.D. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8 (2007) 379-393
12. Foijer F., Draviam V.M., and Sorger P.K. Studying chromosome instability in the mouse. Biochim Biophys Acta 1786 (2008) 73-82
13. Suijkerbuijk S.J., and Kops G.J. Preventing aneuploidy: the contribution of mitotic checkpoint proteins. Biochim Biophys Acta 1786 (2008) 24-31
14. Gascoigne K.E., and Taylor S.S. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14 (2008) 111-122. This paper shows that commonly studied CIN cells lines do not have SAC defects. The paper also provides a comprehensive analysis cell fate after checkpoint activation by antimitotic drugs.
15. Thompson S.L., and Compton D.A. Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol 180 (2008) 665-672. This paper makes several important points. The authors show that merotely, not defects in the spindle assembly checkpoint, generates chromosome mis-segregation in 'CIN' cancer cell lines. They also show that most non-CIN cell lines cannot be induced to become stably aneuploid by increasing chromosome segregation errors.
16. Tighe A., Johnson V.L., Albertella M., and Taylor S.S. Aneuploid colon cancer cells have a robust spindle checkpoint. EMBO Rep 2 (2001) 609-614
17. King R.W. When 2 + 2 = 5: the origins and fates of aneuploid and tetraploid cells. Biochim Biophys Acta 1786 (2008) 4-14
18. Baker D.J., Chen J., and van Deursen J.M. The mitotic checkpoint in cancer and aging: what have mice taught us?. Curr Opin Cell Biol 17 (2005) 583-589
19. Hanks S., Coleman K., Reid S., Plaja A., Firth H., Fitzpatrick D., Kidd A., Mehes K., Nash R., Robin N., et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36 (2004) 1159-1161
20. Matsuura S., Matsumoto Y., Morishima K., Izumi H., Matsumoto H., Ito E., Tsutsui K., Kobayashi J., Tauchi H., Kajiwara Y., et al. Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome. Am J Med Genet A 140 (2006) 358-367
21. Cimini D., Howell B., Maddox P., Khodjakov A., Degrassi F., and Salmon E.D. Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J Cell Biol 153 (2001) 517-527
22. Cimini D. Merotelic kinetochore orientation, aneuploidy, and cancer. Biochim Biophys Acta 1786 (2008) 32-40
23. Cimini D., Wan X., Hirel C.B., and Salmon E.D. Aurora kinase promotes turnover of kinetochore microtubules to reduce chromosome segregation errors. Curr Biol 16 (2006) 1711-1718
24. Knowlton A.L., Lan W., and Stukenberg P.T. Aurora B is enriched at merotelic attachment sites, where it regulates MCAK. Curr Biol 16 (2006) 1705-1710
25. Bakhoum S.F., Thompson S.L., Manning A.L., and Compton D.A. Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat Cell Biol 11 (2009) 27-35. This paper demonstrates the key role of kinetochore-microtubule dynamics on maintenance of genomic stability. Depletion of kinetochore-associated microtubule kinesins led to an increase in lagging chromosomes and subsequent segregation defects. Overexpression of these kinesins, at levels that would not activate the SAC, suppressed chromosome mis-segregation in CIN cell lines to levels comparable to stable diploid cell lines.
26. Nowak M.A., Komarova N.L., Sengupta A., Jallepalli P.V., Shih Ie M., Vogelstein B., and Lengauer C. The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci U S A 99 (2002) 16226-16231
27. Yuen K.W., Warren C.D., Chen O., Kwok T., Hieter P., and Spencer F.A. Systematic genome instability screens in yeast and their potential relevance to cancer. Proc Natl Acad Sci U S A 104 (2007) 3925-3930
28. Kolodner R.D., Putnam C.D., and Myung K. Maintenance of genome stability in Saccharomyces cerevisiae. Science 297 (2002) 552-557
29. Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., Angenendt P., Mankoo P., Carter H., Siu I.M., Gallia G.L., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321 (2008) 1807-1812
30. McLendon R., Friedman A., Bigner D., Van Meir E.G., Brat D.J., Mastrogianakis M., Olson J.J., Mikkelsen T., Lehman N., Aldape K., et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 (2008) 1061-1068
31. Jones S., Zhang X., Parsons D.W., Lin J.C., Leary R.J., Angenendt P., Mankoo P., Carter H., Kamiyama H., Jimeno A., et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321 (2008) 1801-1806
32. Barber T.D., McManus K., Yuen K.W., Reis M., Parmigiani G., Shen D., Barrett I., Nouhi Y., Spencer F., Markowitz S., et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci U S A 105 (2008) 3443-3448. In this study 102 human homologues of 96 yeast CIN genes were sequenced and 11 somatic mutations distributed among five genes in a panel of 132 colorectal cancers were identified.
33. Michor F., Iwasa Y., Vogelstein B., Lengauer C., and Nowak M.A. Can chromosomal instability initiate tumorigenesis?. Semin Cancer Biol 15 (2005) 43-49
34. Frohling S., Scholl C., Levine R.L., Loriaux M., Boggon T.J., Bernard O.A., Berger R., Dohner H., Dohner K., Ebert B.L., et al. Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles. Cancer Cell 12 (2007) 501-513
35. Pihan G.A., Wallace J., Zhou Y., and Doxsey S.J. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 63 (2003) 1398-1404
36. Fukasawa K. Oncogenes and tumour suppressors take on centrosomes. Nat Rev Cancer 7 (2007) 911-924
37. Gonzalez C. Spindle orientation, asymmetric division and tumour suppression in Drosophila stem cells. Nat Rev Genet 8 (2007) 462-472
38. Castellanos E., Dominguez P., and Gonzalez C. Centrosome dysfunction in Drosophila neural stem cells causes tumors that are not due to genome instability. Curr Biol 18 (2008) 1209-1214
39. Caussinus E., and Gonzalez C. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nat Genet 37 (2005) 1125-1129
40. Basto R., Brunk K., Vinadogrova T., Peel N., Franz A., Khodjakov A., and Raff J.W. Centrosome amplification can initiate tumorigenesis in flies. Cell 133 (2008) 1032-1042. This study demonstrates that centrosome amplification in flies does not lead to gross aneuploidy, but can initiate tumorigenesis by disrupting asymmetric cell division.
41. Torres E.M., Williams B.R., and Amon A. Aneuploidy: cells losing their balance. Genetics 179 (2008) 737-746
42. Dyban AP, Baranov, VS: Cytogenetics of Mammalian Embryonic Development. New York/Oxford: Clarendon Press/Oxford University Press; 1987.
43. Niwa O., and Yanagida M. Triploid meiosis and aneuploidy in Schizosaccharomyces pobe: an unstable aneuploid disomic for chromosome III. Curr Genet 9 (1985) 463-470
44. Torres E.M., Sokolsky T., Tucker C.M., Chan L.Y., Boselli M., Dunham M.J., and Amon A. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317 (2007) 916-924. The study characterized the changes in physiology in that occur in aneuploid yeast. The paper describes responses to aneuploidy that are not specific to a given chromosome.
45. ••]), this paper describes proliferative and physiological changes in primary mouse cell lines with four distinct trisomies. The authors show that trisomy affects the rate of immortalization. This effect on immortalization varies with the identity of the extra chromosome.
46. Upender M.B., Habermann J.K., McShane L.M., Korn E.L., Barrett J.C., Difilippantonio M.J., and Ried T. Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res 64 (2004) 6941-6949
47. Tsafrir D., Bacolod M., Selvanayagam Z., Tsafrir I., Shia J., Zeng Z., Liu H., Krier C., Stengel R.F., Barany F., et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 66 (2006) 2129-2137
48. Castedo M., Coquelle A., Vivet S., Vitale I., Kauffmann A., Dessen P., Pequignot M.O., Casares N., Valent A., Mouhamad S., et al. Apoptosis regulation in tetraploid cancer cells. EMBO J 25 (2006) 2584-2595
49. Galitski T., Saldanha A.J., Styles C.A., Lander E.S., and Fink G.R. Ploidy regulation of gene expression. Science 285 (1999) 251-254
50. Storchova Z., Breneman A., Cande J., Dunn J., Burbank K., O'Toole E., and Pellman D. Genome-wide genetic analysis of polyploidy in yeast. Nature 443 (2006) 541-547
51. Weaver B.A., Silk A.D., Montagna C., Verdier-Pinard P., and Cleveland D.W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11 (2007) 25-36. Heterozygous Cenp-e mice were shown to develop aneuploidy and chromosome instability, leading to the development of spontaneous tumors in certain tissues. However, on other genetic backgrounds this mutation suppressed tumor formation.
52. Sotillo R., Hernando E., Diaz-Rodriguez E., Teruya-Feldstein J., Cordon-Cardo C., Lowe S.W., and Benezra R. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11 (2007) 9-23
53. Sussan T.E., Yang A., Li F., Ostrowski M.C., and Reeves R.H. Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature 451 (2008) 73-75
54. Hughes T.R., Roberts C.J., Dai H., Jones A.R., Meyer M.R., Slade D., Burchard J., Dow S., Ward T.R., Kidd M.J., et al. Widespread aneuploidy revealed by DNA microarray expression profiling. Nat Genet 25 (2000) 333-337
55. Selmecki A., Gerami-Nejad M., Paulson C., Forche A., and Berman J. An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1. Mol Microbiol 68 (2008) 624-641. This study demonstrated that aneuploidy was responsible for drug resistance in clinical isolates of Candida albicans.
56. Rancati G., Pavelka N., Fleharty B., Noll A., Allen R., Walton K., Perera A., Staehling-Hampton K., Seidel C.W., and Li R. Aneuploidy and polyploidy underlie adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell 135 (2008) 879-893. In vitro evolution was used to identify yeast strains that adapted to a cytokinesis defect. Genomic methods, including genome re-sequencing, defined mechanisms leading to adaptation. Aneuploidy, possibly developing from polyploidy, appeared to the major mechanism of adaptation.
57. Galhardo R.S., Hastings P.J., and Rosenberg S.M. Mutation as a stress response and the regulation of evolvability. Crit Rev Biochem Mol Biol 42 (2007) 399-435
58. Bristow R.G., and Hill R.P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8 (2008) 180-192
59. Roth J.R., Kugelberg E., Reams A.B., Kofoid E., and Andersson D.I. Origin of mutations under selection: the adaptive mutation controversy. Annu Rev Microbiol 60 (2006) 477-501
60. Gasch A.P., Spellman P.T., Kao C.M., Carmel-Harel O., Eisen M.B., Storz G., Botstein D., and Brown P.O. Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell 11 (2000) 4241-4257
61. Mayer V.W., and Aguilera A. High levels of chromosome instability in polyploids of Saccharomyces cerevisiae. Mutat Res 231 (1990) 177-186
62. Fujiwara T., Bandi M., Nitta M., Ivanova E.V., Bronson R.T., and Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437 (2005) 1043-1047
63. Roh M., Franco O.E., Hayward S.W., van der Meer R., and Abdulkadir S.A. A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells. PLoS ONE 3 (2008) e2572
64. Kwon M., Godinho S.A., Chandhok N.S., Ganem N.J., Azioune A., Thery M., and Pellman D. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev 22 (2008) 2189-2203. This study used RNAi to define the factors that suppress multipolar mitoses in cells with extra centrosomes. The study validates the idea that inhibiting centrosome clustering can kill cancer cells with extra centrosomes but not normal controls.
65. - patients.